Seattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal

By Sam | February 9, 2017

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-deal3.jpg" NAME"Seattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal" ALT"Seattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal"February 10, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR…
Source: BioSpace

Posted in BioPharma